-
Something wrong with this record ?
Pharmacokinetics of leptin in female mice
R. A. Hart, R. C. Dobos, L. L. Agnew, R. L. Tellam, J. R. McFarlane
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Hypothalamus drug effects metabolism MeSH
- Injections, Intravenous MeSH
- Leptin administration & dosage blood pharmacokinetics MeSH
- Metabolic Clearance Rate drug effects physiology MeSH
- Mice MeSH
- Half-Life MeSH
- Cattle MeSH
- Tissue Distribution drug effects physiology MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Cattle MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Pharmacokinetics of leptin in mammals has received limited attention and only one study has examined more than two time points and this was in ob/ob mice. This study is the first to observe the distribution of leptin over a time course in female mice. A physiologic dose (12 ng) of radiolabelled leptin was injected in adult female mice via the lateral tail vein and tissues were dissected out and measured for radioactivity over a time course up to two hours. Major targets for administered leptin included the liver, kidneys, gastrointestinal tract and the skin while the lungs had high concentrations of administered leptin per gram of tissue. Leptin was also found to enter the lumen of the digestive tract intact from the plasma. Very little of the dose (<1 %) was recovered from the brain at any time. Consequently we confirm that the brain is not a major target for leptin from the periphery, although it may be very sensitive to leptin that does get to the hypothalamus. Several of the major targets (GI tract, skin and lungs) for leptin form the interface for the body with the environment, and given the ability of leptin to modulate immune function, this may represent a priming effect for tissues to respond to damage and infection.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17010629
- 003
- CZ-PrNML
- 005
- 20170329133653.0
- 007
- ta
- 008
- 170321s2016 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933053 $2 doi
- 035 __
- $a (PubMed)26447522
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Hart, R. A. $u Centre for Bioactive Discovery in Health and Ageing, University of New England, Armidale, NSW 2351, Australia
- 245 10
- $a Pharmacokinetics of leptin in female mice / $c R. A. Hart, R. C. Dobos, L. L. Agnew, R. L. Tellam, J. R. McFarlane
- 520 9_
- $a Pharmacokinetics of leptin in mammals has received limited attention and only one study has examined more than two time points and this was in ob/ob mice. This study is the first to observe the distribution of leptin over a time course in female mice. A physiologic dose (12 ng) of radiolabelled leptin was injected in adult female mice via the lateral tail vein and tissues were dissected out and measured for radioactivity over a time course up to two hours. Major targets for administered leptin included the liver, kidneys, gastrointestinal tract and the skin while the lungs had high concentrations of administered leptin per gram of tissue. Leptin was also found to enter the lumen of the digestive tract intact from the plasma. Very little of the dose (<1 %) was recovered from the brain at any time. Consequently we confirm that the brain is not a major target for leptin from the periphery, although it may be very sensitive to leptin that does get to the hypothalamus. Several of the major targets (GI tract, skin and lungs) for leptin form the interface for the body with the environment, and given the ability of leptin to modulate immune function, this may represent a priming effect for tissues to respond to damage and infection.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a skot $7 D002417
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a poločas $7 D006207
- 650 _2
- $a hypothalamus $x účinky léků $x metabolismus $7 D007031
- 650 _2
- $a injekce intravenózní $7 D007275
- 650 _2
- $a leptin $x aplikace a dávkování $x krev $x farmakokinetika $7 D020738
- 650 _2
- $a metabolická clearance $x účinky léků $x fyziologie $7 D008657
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a tkáňová distribuce $x účinky léků $x fyziologie $7 D014018
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dobos, R. C. $u NSW Department of Primary Industries, Armidale, NSW, Australia
- 700 1_
- $a Agnew, L. L. $u Centre for Bioactive Discovery in Health and Ageing, University of New England, Armidale, NSW 2351, Australia $7 gn_A_00002210
- 700 1_
- $a Tellam, R. L. $u CSIRO Tropical Animal Production/Livestock Industries, Brisbane, QLD, Australia
- 700 1_
- $a McFarlane, J. R. $u Centre for Bioactive Discovery in Health and Ageing, University of New England, Armidale, NSW 2351, Australia
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 65, č. 2 (2016), s. 311-320
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20170321 $b ABA008
- 991 __
- $a 20170327130404 $b ABA008
- 999 __
- $a ok $b bmc $g 1196375 $s 971346
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 65 $c 2 $d 311-320 $e 20151008 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20170321